Overview

[C-11]PiB PET Imaging in Alcohol Use Disorders

Status:
Completed

Trial end date:
2020-07-01

Target enrollment:

Participant gender:

Summary

To determine whether alcoholics (AUD) have a greater rate of amyloid positivity (ABeta+) compared to an age-matched cognitively normal control group (HC).

Phase:

Early Phase 1

Details

Lead Sponsor:

University of Pittsburgh

Collaborator:

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Treatments:

Corticosterone